Baker Hughes 2014 Annual Report Download - page 88

Download and view the complete annual report

Please find page 88 of the 2014 Baker Hughes annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 122

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122

Baker Hughes Incorporated
Notes to Consolidated Financial Statements
63
The following table presents the changes in stock options outstanding and related information (in thousands,
except per option prices):
Number of
Options
Weighted Average
Exercise Price
Per Option
Outstanding at December 31, 2013 12,206 $ 50.57
Granted 1,089 63.67
Exercised (3,158) 44.06
Forfeited (231) 51.71
Expired (169) 69.10
Outstanding at December 31, 2014 9,737 $ 53.80
Exercisable at December 31, 2014 6,719 $ 54.80
The weighted average remaining contractual term for options outstanding and options exercisable at
December 31, 2014 were 5.7 years and 4.5 years, respectively.
The total intrinsic value of stock options (defined as the amount by which the market price of our common stock
on the date of exercise exceeds the exercise price of the option) exercised in 2014, 2013 and 2012 was $70 million,
$11 million and $3 million, respectively. The income tax benefit realized from stock options exercised was $19.6
million, $2.0 million and $0.8 million in 2014, 2013 and 2012, respectively.
The total fair value of options vested in 2014, 2013 and 2012 was $29 million, $31 million and $28 million,
respectively. As of December 31, 2014, there was $15 million of total unrecognized compensation cost related to
unvested stock options, which is expected to be recognized over a weighted average period of two years.
The total intrinsic value of stock options outstanding at December 31, 2014 was $74 million, of which $53 million
relates to options vested and exercisable. The intrinsic value for stock options outstanding is calculated as the
amount by which the quoted price of $56.07 of our common stock as of the end of 2014 exceeds the exercise price
of the options.
Restricted Stock Awards and Units
In addition to stock options, our officers, directors and key employees may be granted restricted stock awards
(“RSA”), which is an award of common stock with no exercise price, or restricted stock units (“RSU”), where each
unit represents the right to receive, at the end of a stipulated period, one unrestricted share of stock with no
exercise price. RSAs and RSUs are subject to cliff or graded vesting, generally ranging over a three year period, or
over a one year period for non-employee directors. We determine the fair value of restricted stock awards and
restricted stock units based on the market price of our common stock on the date of grant. The following table
presents the combined changes of RSAs and RSUs and related information (in thousands, except per award/unit
prices):
Number of
Awards
and Units
Weighted Average
Grant Date Fair
Value Per Award/Unit
Unvested balance at December 31, 2013 2,652 $ 47.44
Granted 1,498 69.67
Vested (1,206) 49.79
Forfeited (212) 56.63
Unvested balance at December 31, 2014 2,732 $ 57.88